Financials
- Market Capitalization 13.53 M
- Employee 1
- Founded N/A
- CEO N/A
- Website www.gtbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG000DHJ738
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4696 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.42 USD | -4.55% | +10.53% | -12.50% | -60.00% | 13.67 M USD | ||
| 4697 | ICU SeaStar Medical Holding Corporation - Common Stock | 3.09 USD | -0.32% | -8.85% | -6.36% | +25.61% | 13.62 M USD | ||
| 4703 | KALA KALA BIO, Inc. - Common Stock | 0.69 USD | -13.75% | -15.85% | 0.00% | -94.25% | 13.34 M USD | ||
| 4706 | PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.13 USD | +0.89% | -5.04% | +16.49% | -5.04% | 13.13 M USD |
Frequently asked questions about GT Biopharma Inc. Common Stock
What is the GT Biopharma Inc. Common Stock stock price today?
The current price of GT Biopharma Inc. Common Stock (GTBP) is 0.30. Over the past 24 hours, the stock has changed by 0.00%. Follow the GTBP chart for real-time price dynamics.
What is the stock ticker of GT Biopharma Inc. Common Stock?
GT Biopharma Inc. Common Stock trades under the ticker GTBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is GT Biopharma Inc. Common Stock stock going up?
GTBP has changed by +3.45% over the last week, 0.00% over the last month, and -67.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of GT Biopharma Inc. Common Stock?
GT Biopharma Inc. Common Stock currently has a market capitalization of 13.53 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were GT Biopharma Inc. Common Stock earnings last quarter?
Last quarter, GT Biopharma Inc. Common Stock reported earnings of -0.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was GT Biopharma Inc. Common Stock revenue for the last quarter?
GT Biopharma Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was GT Biopharma Inc. Common Stock net income for the last quarter?
GT Biopharma Inc. Common Stock reported net income of -4.52 M for the last quarter. The previous quarter showed -2.83 M, which means net income changed by -59.48%.
How many employees does GT Biopharma Inc. Common Stock have?
As of the latest available data, GT Biopharma Inc. Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy GT Biopharma Inc. Common Stock stock?
You can buy GT Biopharma Inc. Common Stock (GTBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in GT Biopharma Inc. Common Stock stock?
Investing in GT Biopharma Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GTBP chart and related analysis on metatrader.com as part of your research.